Page last updated: 2024-08-25

honokiol and Multiple Myeloma

honokiol has been researched along with Multiple Myeloma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbiser, JL; Bonner, MY; Cebula-Obrzut, B; Majchrzak, A; Mędra, A; Robak, T; Smolewski, P; Witkowska, M1
Anderson, KC; Arbiser, J; Chauhan, D; Hamasaki, M; Hideshima, H; Hideshima, T; Ishitsuka, K; Kumar, S; Le Gouill, S; Podar, K; Raje, N; Richardson, P; Roccaro, AM; Shiraishi, N; Tamura, K; Yasui, H1

Other Studies

2 other study(ies) available for honokiol and Multiple Myeloma

ArticleYear
Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.
    Molecules (Basel, Switzerland), 2016, Jul-30, Volume: 21, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Lymphoma; Multiple Myeloma; Trityl Compounds

2016
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
    Blood, 2005, Sep-01, Volume: 106, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Bone Marrow Cells; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Endothelial Cells; Humans; Insulin-Like Growth Factor I; Interleukin-6; Lignans; Multiple Myeloma; Neovascularization, Pathologic; Stromal Cells; Structure-Activity Relationship

2005